Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.
about
Multilocus sequence typing of serially collected isolates of Cryptococcus from HIV-infected patients in South Africa.Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal studyCryptococcal Meningitis: Diagnosis and Management Update.The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans.Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii.Leveraging a high resolution microfluidic assay reveals insights into pathogenic fungal spore germinationA multiplex real-time PCR assay for identification of Pneumocystis jirovecii, Histoplasma capsulatum, and Cryptococcus neoformans/Cryptococcus gattii in samples from AIDS patients with opportunistic pneumonia.New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.Fluconazole resistance in cryptococcal disease: emerging or intrinsic?A paradoxical decline: intracranial lesions in two HIV-positive patients recovering from cryptococcal meningitis.Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.A subdose of fluconazole alters the virulence of Cryptococcus gattii during murine cryptococcosis and modulates type I interferon expression.Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.Comparison of different in vitro tests to detect Cryptococcus neoformans not susceptible to amphotericin B.Antifungal Susceptibility Testing of Candida and Cryptococcus Species and Mechanisms of Resistance: Implications for Clinical Laboratories
P2860
Q33703545-A23BD023-20CF-4024-AA12-60DA487175CDQ35700772-AA5D2A3C-2B01-41D0-9FD4-9FCB302DD47AQ35951094-85BBB05B-EBC6-4251-A36D-DD36DC8A8F7EQ36344094-0A9A0018-8B81-4423-B7D9-13678C1E19B4Q36364064-3AF390DA-8569-4D69-8D68-611FE4331676Q36440166-3B22DEC8-1641-4109-B7E5-1E3B505E8402Q36730109-09621E04-176B-456C-9A37-EE4D221F58B8Q36905574-85681F08-0648-4E07-AC38-07D322F9AD15Q37713483-F509814C-CFC0-46E3-951E-AE66EC74A303Q38024052-BF1293D7-D3CF-46C6-BD1E-567460C807D4Q38044487-B2775C1B-01A5-4D35-BA68-C9DB6E4E430CQ38609663-228D3A3C-291F-4D26-ABC0-6F17572F8AEFQ38851467-F72EBCA7-07D9-41A5-AA23-394AF8237C5DQ39030373-B94ACB78-13D1-4AAA-88C7-59D0892AA801Q39530506-CF9A7181-8B37-41D1-885C-0940302048A2Q40796391-9168D1D8-75BE-453E-8CCD-485EB7FB4408Q41472967-26162A55-8A8D-4D00-B898-510AB9720A45Q57745988-3B75B31C-C6BF-4C00-A0D1-E3946D151032
P2860
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Trends in antifungal drug susc ...... ca in 2002-2003 and 2007-2008.
@ast
Trends in antifungal drug susc ...... ca in 2002-2003 and 2007-2008.
@en
type
label
Trends in antifungal drug susc ...... ca in 2002-2003 and 2007-2008.
@ast
Trends in antifungal drug susc ...... ca in 2002-2003 and 2007-2008.
@en
prefLabel
Trends in antifungal drug susc ...... ca in 2002-2003 and 2007-2008.
@ast
Trends in antifungal drug susc ...... ca in 2002-2003 and 2007-2008.
@en
P2093
P2860
P356
P1476
Trends in antifungal drug susc ...... ca in 2002-2003 and 2007-2008.
@en
P2093
Group for Enteric, Respiratory ...... nce in South Africa (GERMS-SA)
Jaymati Patel
Marelize van Wyk
Nelesh P Govender
Tom M Chiller
P2860
P304
P356
10.1128/AAC.00048-11
P407
P577
2011-03-28T00:00:00Z